Trials / Completed
CompletedNCT00279344
Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)
A Randomised, Open, Parallel-group, Multi-centre Trial to Investigate Analgesic Efficacy and Safety of Transdermal Fentanyl (FITpatch) Compared to Standard Opioid Treatment in Cancer Pain.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 220 (planned)
- Sponsor
- Nycomed · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Primary objectives: * To determine non-inferiority of FITpatch with regard to efficacy compared to standard opioid treatment * To assess the safety of FITpatch compared to standard opioid treatment Secondary objectives: * To assess the intake of oral morphine as rescue analgesic to FITpatch compared to standard opioid treatment * To assess Quality of life reported with FITpatch compared to standard opioid treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fentanyl (Matrifen) |
Timeline
- Start date
- 2004-09-01
- Completion
- 2007-08-01
- First posted
- 2006-01-19
- Last updated
- 2012-05-07
Source: ClinicalTrials.gov record NCT00279344. Inclusion in this directory is not an endorsement.